
Transforming healthcare through cutting-edge cellular therapy solutions. We deliver innovative treatments backed by rigorous scientific research.

The most promising exosome therapeutics ever for digestive tissue healing and organ regeneration.
Exosomes are nanoscale vesicles naturally secreted by cells and serve as key mediators of intercellular communication. They carry a wide range of bioactive molecules, including proteins and nucleic acids, demonstrating significant potential in immune regulation, tissue repair, and anti-aging applications.
NAD⁺ targeted enhancement technology enriches high-activity NAD⁺ by optimizing cellular metabolism and exosome loading processes. This effectively enhances bioactivity, targeting, and in vivo stability of exosomes, extending their action duration and strengthening anti-aging and repair effects.

Our proprietary dual pipeline leverages high-quality cell sources to develop function-oriented cellular and exosome products with well-defined biological profiles, focusing on anti-aging and tissue repair applications.
Advanced cell engineering for immunocyte-derived products with enhanced bioactivity.
High-quality mesenchymal stem cells integrated with NAD⁺ enhancement technology.

We are a pioneering biotechnology company advancing cellular therapy through innovative research and clinical excellence, transforming patient care with scientifically validated treatments.
Founded in 2025, TheraExo stands among the pioneers in exosome-based therapies, a significant revolution in the current therapeutic landscape of gene and cell therapies. Exosomes are biological nanoparticles secreted by cells that currently raise growing interest within the pharmaceutical industry due to their potent role in intercellular communication.
They hold promising properties for treating a wide range of diseases with high unmet medical need. Winner of the European EIC Accelerator Program, TheraExo aims to become the leading biotech in this field.
The company has successfully developed an innovation platform protected by several patents, covering the entire technological value chain: cell sourcing, exosome generation, exosome loading, and formulation.

Mark Wanner
mark@gmail.com
“Our dedicated patient engagement app and web portal allow you to access information instantaneously (no tedious forms, long calls, or administrative hassle) and securely.”
Stay updated with the latest developments in exosome therapy and cellular medicine research